journal
https://read.qxmd.com/read/39390105/effects-of-ketamine-on-gabaergic-and-glutamatergic-activity-in-the-mpfc-biphasic-recruitment-of-gaba-function-in-antidepressant-like-responses
#1
JOURNAL ARTICLE
Manoela V Fogaça, Fernanda Daher, Marina R Picciotto
Major depressive disorder (MDD) is associated with disruptions in glutamatergic and GABAergic activity in the medial prefrontal cortex (mPFC), leading to altered synaptic formation and function. Low doses of ketamine rapidly rescue these deficits, inducing fast and sustained antidepressant effects. While it is suggested that ketamine produces a rapid glutamatergic enhancement in the mPFC, the temporal dynamics and the involvement of GABA interneurons in its sustained effects remain unclear. Using simultaneous photometry recordings of calcium activity in mPFC pyramidal and GABA neurons, as well as chemogenetic approaches in Gad1-Cre mice, we explored the hypothesis that initial effects of ketamine on glutamate signaling trigger subsequent enhancement of GABAergic responses, contributing to its sustained antidepressant responses...
October 11, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39384894/investigating-cross-sectional-and-longitudinal-relationships-between-brain-structure-and-distinct-dimensions-of-externalizing-psychopathology-in-the-abcd-sample
#2
JOURNAL ARTICLE
Hajer Nakua, Lee Propp, Anne-Claude V Bedard, Marcos Sanches, Stephanie H Ameis, Brendan F Andrade
Externalizing psychopathology in childhood is a predictor of poor outcomes across the lifespan. Children exhibiting elevated externalizing symptoms also commonly show emotion dysregulation and callous-unemotional (CU) traits. Examining cross-sectional and longitudinal neural correlates across dimensions linked to externalizing psychopathology during childhood may clarify shared or distinct neurobiological vulnerability for psychopathological impairment later in life. We used tabulated brain structure and behavioural data from baseline, year 1, and year 2 timepoints of the Adolescent Brain Cognitive Development Study (ABCD; baseline n = 10,534)...
October 9, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39362985/medial-prefrontal-cortex-acetylcholine-signaling-mediates-the-ability-to-learn-an-active-avoidance-response-following-learned-helplessness-training
#3
JOURNAL ARTICLE
Zuhair I Abdulla, Yann S Mineur, Richard B Crouse, Ian M Etherington, Hanna Yousuf, Jessica J Na, Marina R Picciotto
Increased brain levels of acetylcholine (ACh) have been observed in patients with depression, and increasing ACh levels pharmacologically can precipitate stress-related behaviors in humans and animals. Conversely, optimal ACh levels are required for cognition and memory. We hypothesize that excessive ACh signaling results in strengthening of negative encoding in which memory formation is aberrantly strengthened for stressful events. The medial prefrontal cortex (mPFC) is critical for both top-down control of stress-related circuits, and for encoding of sensory experiences...
October 3, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39358543/a-digital-intervention-for-cognitive-deficits-following-covid-19-a-randomized-clinical-trial
#4
JOURNAL ARTICLE
Lindsay W Victoria, Lauren E Oberlin, Irena P Ilieva, Abhishek Jaywant, Dora Kanellopoulos, Catherine Mercaldi, Caitlin A Stamatis, Deborah N Farlow, Scott H Kollins, Ochuwa Tisor, Sama Joshi, Raura Doreste-Mendez, Roy H Perlis, Faith M Gunning
Post-COVID-19 cognitive deficits are common, persistent, and disabling. Evidence on effective treatments is limited. The goal of this study was to investigate the efficacy of a digital intervention to reduce cognitive and functional deficits in adults with persistent post-COVID-19 cognitive dysfunction. We used the remotely-delivered intervention in a randomized clinical trial conducted from July 13, 2021 to April 26, 2023. We hypothesized that participants in the intervention group would improve in measures of cognition and daily functioning...
October 2, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39327472/inhibition-of-striatal-indirect-pathway-during-second-postnatal-week-leads-to-long-lasting-deficits-in-motivated-behavior
#5
JOURNAL ARTICLE
Pedro R Olivetti, Arturo Torres-Herraez, Meghan E Gallo, Ricardo Raudales, MaryElena Sumerau, Sinead Moyles, Peter D Balsam, Christoph Kellendonk
Schizophrenia is a neuropsychiatric disorder with postulated neurodevelopmental etiology. Genetic and imaging studies have shown enhanced dopamine and D2 receptor occupancy in the striatum of patients with schizophrenia. However, whether alterations in postnatal striatal dopamine can lead to long-lasting changes in brain function and behavior is still unclear. Here, we approximated striatal D2R hyperfunction in mice via designer receptor-mediated activation of inhibitory Gi-protein signaling during a defined postnatal time window...
September 26, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39313675/effects-of-intranasal-oxytocin-on-fear-extinction-learning
#6
JOURNAL ARTICLE
Mahmoud Rashidi, Joe J Simon, Katja Bertsch, Gerhard Vincent Wegen, Beate Ditzen, Herta Flor, Valery Grinevich, Robert Christian Wolf, Sabine C Herpertz
Once a threat no longer exists, extinction of conditioned fear becomes adaptive in order to reduce allotted resources towards cues that no longer predict the threat. In anxiety and stress disorders, fear extinction learning may be affected. Animal findings suggest that the administration of oxytocin (OT) modulates extinction learning in a timepoint-dependent manner, facilitating extinction when administered prior to fear conditioning, but impairing it when administered prior to extinction learning. The aim of the present study was to examine if these findings translate into human research...
September 24, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39304744/cathepsin-b-modulates-microglial-migration-and-phagocytosis-of-amyloid-%C3%AE-in-alzheimer-s-disease-through-pi3k-akt-signaling
#7
JOURNAL ARTICLE
Muzhou Jiang, Dan Zhao, Yue Zhou, Wei Kong, Zhen Xie, Yijie Xiong, Yanhui Li, Shuxuan Zhao, Xueshuai Kou, Simeng Zhang, Rui Meng, Yaping Pan, Zhou Wu, Hiroshi Nakanishi, Juan Zhao, Hui Li, Zhenzhen Quan, Li Lin, Hong Qing, Junjun Ni
The approval of anti-amyloid β (Aβ) monoclonal antibodies (lecanemab) for the treatment of patients with early preclinical stage of Alzheimer's disease (AD) by the Food and Drug Administration, suggests the reliability and importance of brain Aβ clearance for AD therapy. Microglia are the main phagocytes that clear Aβ in the brain, but the underlying regulatory mechanism is unclear. Here, we investigate the critical role of cathepsin B (CatB) in modulating microglial Aβ clearance from mouse brain...
September 20, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39304743/vasopressin-regulates-social-play-behavior-in-sex-specific-ways-through-glutamate-modulation-in-the-lateral-septum
#8
JOURNAL ARTICLE
Remco Bredewold, Catherine Washington, Alexa H Veenema
Understanding the neural basis of social play in juvenile rats may ultimately help restore social play deficits in autistic children. We previously found that administration of a vasopressin (AVP) V1a receptor (V1aR) antagonist into the lateral septum (LS) increased social play behavior in male juvenile rats and decreased it in females. Here, we demonstrate that glutamate, but not GABA, is involved in this sex-specific regulation. First, we found a sex difference in extracellular LS glutamate/GABA ratio (lower in females) that was eliminated by V1aR antagonist infusion in the LS that caused an increase in glutamate release in females only...
September 20, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39300273/role-of-serotonin-neurons-in-the-dorsal-raphe-nucleus-in-heroin-self-administration-and-punishment
#9
JOURNAL ARTICLE
Chen Li, Nicholas S McCloskey, Saadet Inan, Lynn G Kirby
One hallmark of substance use disorder is continued drug use despite negative consequences. When drug-taking behavior is punished with aversive stimuli, i.e. footshock, rats can also be categorized into punishment-resistant or compulsive vs. punishment-sensitive or non-compulsive phenotypes. The serotonin (5-hydroxytryptamine, 5-HT) system modulates responses to both reward and punishment. The goal of the current study was to examine punishment phenotypes in heroin self-administration and to determine the role of dorsal raphe nucleus (DRN) 5-HT neurons in both basal and punished heroin self-administration...
September 19, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39300272/dopamine-transmission-at-d1-and-d2-receptors-in-the-nucleus-accumbens-contributes-to-the-expression-of-incubation-of-cocaine-craving
#10
JOURNAL ARTICLE
Sophia J Weber, Alex B Kawa, Madelyn M Beutler, Hayley M Kuhn, Alana L Moutier, Jonathan G Westlake, Lara M Koyshman, Cloe D Moreno, Amanda M Wunsch, Marina E Wolf
Relapse represents a consistent clinical problem for individuals with substance use disorder. In the incubation of craving model of persistent craving and relapse, cue-induced drug seeking progressively intensifies or "incubates" during the first weeks of abstinence from drug self-administration and then remains high for months. Previously, we and others have demonstrated that expression of incubated cocaine craving requires strengthening of excitatory synaptic transmission in the nucleus accumbens core (NAcc)...
September 19, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39300270/role-of-dorsal-striatum-circuits-in-relapse-to-opioid-seeking-after-voluntary-abstinence
#11
JOURNAL ARTICLE
Zilu Ma, Ying Duan, Ida Fredriksson, Pei-Jung Tsai, Ashley Batista, Hanbing Lu, Yavin Shaham, Yihong Yang
High relapse rate during abstinence is a defining characteristic of drug addiction. We previously found that opioid seeking progressively increases after voluntary abstinence induced by adverse consequences of oxycodone seeking (crossing an electric barrier). Functional MRI revealed that this effect is associated with changes in functional connectivity within medial orbitofrontal cortex (mOFC)- and dorsomedial striatum (DMS)-related circuits. Here, we used a pharmacological manipulation and fMRI to determine the causal role of mOFC and DMS in oxycodone seeking after electric barrier-induced abstinence...
September 19, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39300271/memory-engram-stability-and-flexibility
#12
REVIEW
Yosif Zaki, Denise J Cai
Many studies have shown that memories are encoded in sparse neural ensembles distributed across the brain. During the post-encoding period, often during sleep, many of the cells that were active during encoding are reactivated, supporting consolidation of this memory. During memory recall, many of the same cells that were active during encoding and reactivated during consolidation are reactivated during recall. These ensembles of cells have been referred to as the memory engram cells, stably representing a specific memory...
September 18, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39289489/the-anxiogenic-drug-yohimbine-is-a-reinforcer-in-male-and-female-rats
#13
JOURNAL ARTICLE
Briana Renda, Francesco Leri
The indole alkaloid yohimbine is an anxiogenic drug that activates stress-responsive systems in the brain. However, because yohimbine also elicits approach behaviors, this study employed male and female Sprague-Dawley rats to explore its potential reinforcing effects. Thus, it was first determined if intravenous (IV) infusions of yohimbine (0.25 mg/kg/infusion) could maintain lever pressing, whether intake could be modulated by dose/infusion, and if lever pressing would persist in the absence of yohimbine or yohimbine-paired cues...
September 17, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39289488/in-memoriam-burton-m-angrist-md
#14
EDITORIAL
Erica Duncan, John Rotrosen, Adam Wolkin
No abstract text is available yet for this article.
September 17, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39285227/a-covert-cortical-ensemble-for-learned-fear-suppression
#15
JOURNAL ARTICLE
Rebecca M Shansky, Eliza M Greiner
No abstract text is available yet for this article.
September 16, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39285226/reframing-addiction-it-s-not-the-destination-but-the-journey
#16
JOURNAL ARTICLE
Emma Childs
No abstract text is available yet for this article.
September 16, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39285225/pet-imaging-in-rat-brain-shows-opposite-effects-of-acute-and-chronic-alcohol-exposure-on-phosphodiesterase-4b-an-indirect-biomarker-of-camp-activity
#17
JOURNAL ARTICLE
Shiyu Tang, Sung Won Kim, Amanda Olsen-Dufour, Torben Pearson, Michael Freaney, Erick Singley, Madeline Jenkins, Nathaniel J Burkard, Aaron Wozniak, Paul Parcon, Shawn Wu, Cheryl L Morse, Susovan Jana, Jeih-San Liow, Sami S Zoghbi, Janaina C M Vendruscolo, Leandro F Vendruscolo, Victor W Pike, George F Koob, Nora D Volkow, Robert B Innis
The cyclic adenosine monophosphate (cAMP) cascade is thought to play an important role in regulating alcohol-dependent behaviors, with potentially opposite effects following acute versus chronic administration. Phosphodiesterase 4 (PDE4) is the primary brain enzyme that metabolizes cAMP, thereby terminating its signal. Radioligand binding to PDE4 serves as an indirect biomarker of cAMP activity, as cAMP-protein kinase A (PKA)-mediated phosphorylation of PDE4 increases its affinity for radioligand binding ~10-fold...
September 16, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39266652/the-might-of-light-for-revealing-neuropsychiatric-mechanisms
#18
Kutlu Kaya, Hilary P Blumberg
No abstract text is available yet for this article.
September 12, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39251775/correction-identifying-dysfunctional-cell-types-and-circuits-in-animal-models-for-psychiatric-disorders-with-calcium-imaging
#19
Mark M Gergues, Lahin K Lalani, Mazen A Kheirbek
No abstract text is available yet for this article.
September 9, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/39251774/leveraging-ultra-high-field-7t-mri-in-psychiatric-research
#20
REVIEW
Finnegan J Calabro, Ashley C Parr, Valerie J Sydnor, Hoby Hetherington, Konasale M Prasad, Tamer S Ibrahim, Deepak K Sarpal, Alyssa Famalette, Piya Verma, Beatriz Luna
Non-invasive brain imaging has played a critical role in establishing our understanding of the neural properties that contribute to the emergence of psychiatric disorders. However, characterizing core neurobiological mechanisms of psychiatric symptomatology requires greater structural, functional, and neurochemical specificity than is typically obtainable with standard field strength MRI acquisitions (e.g., 3T). Ultra-high field (UHF) imaging at 7 Tesla (7T) provides the opportunity to identify neurobiological systems that confer risk, determine etiology, and characterize disease progression and treatment outcomes of major mental illnesses...
September 9, 2024: Neuropsychopharmacology
journal
journal
30084
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.